<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>TRETIN.X- tretinoinÂ creamÂ </strong><br>Onset Dermatologics LLC<br></p></div>
<h1>Tretinâ€¢X (tretinoin) USP</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="e98b45be-eec3-4fa9-9028-806e80ed61b0"></a><a name="section-1"></a><p></p>
<h1>Description</h1>
<p class="First">TRETINâ€¢X Cream,USP is used for the topical treatment of
                            <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span>.Each gram of TRETINâ€¢X cream contains tretinoin in
                            either of five strengths,0.1% (1 mg), 0.075% (0.75 mg) 0.05%
                            (0.5 mg), 0.0375% (0.375 mg) or 0.025% (0.25 mg) in a
                            hydrophilic cream vehicle of stearic acid,isopropyl myristate, polyoxyl
                            40 stearate,stearyl alcohol,xanthan gum,sorbic acid,butylated
                            hydroxytoluene and purified water.Chemically,tretinoin is <span class="Italics"><span class="Emphasis">all-trans</span></span>-retinoic acid.It has a molecular
                            weight of 300.44 and has the following structural formula:
                                </p>
<p>Â Â <img alt="chemical structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1cecc7e2-00bd-4c63-af1d-723aaf892f60&amp;name=tretinx-figure-1-chemical_structure.jpg">C<span class="Sub">20</span>H<span class="Sub">28</span>O<span class="Sub">2</span></p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="dc37fc11-9957-4d5b-8ea2-a508b89b4294"></a><a name="section-2"></a><p></p>
<h1>Clinical Pharmacology</h1>
<p class="First">Although the exact mode of action of TRETINâ€¢X is
                            unknown,current evidence suggests that topical tretinoin decreases
                            cohesiveness of follicular epithelial cells with decreased microcomedo
                            formation.Additionally,tretinoin stimulates mitotic activity and
                            increased turnover of follicular epithelial cells causing extrusion of
                            the comedones.</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="de204c09-9cdc-49e9-914e-941e6c8791a0"></a><a name="section-3"></a><p></p>
<h1>Indications &amp; Usage</h1>
<p class="First">TRETINâ€¢X cream is indicated for topical application in
                            the treatment of <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne vulgaris</span>.The safety and efficacy of the long-term
                            use of this product in the treatment of other disorders have not been
                            established.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="fd9d58ff-2557-4612-9c1e-6fe09bd0eed4"></a><a name="section-4"></a><p></p>
<h1>Contraindications</h1>
<p class="First">Use of the product should be discontinued if <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>
                            to any of the ingredients is noted.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="d2472bce-cdea-4e7b-9823-0096a93d81a3"></a><a name="section-5"></a><p></p>
<h1>Warnings</h1>
<p class="First">Keep out of reach of children.Keep tube tightly closed.Do not
                            expose to heat or store at temperatures above 120Â°F (49Â°C).
                        </p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="e183aaa3-05e3-46d5-87d6-d90fd4088e28"></a><a name="section-6"></a><p></p>
<h1>Precautions</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="f48fad0c-b628-4ad4-93e6-4ba084189a14"></a><a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First">If a reaction suggesting sensitivity or chemical
                                    irritation occurs,use of the medication should be
                                    discontinued.Exposure to sunlight,including sunlamps, should be
                                    minimized during the use of TRETINâ€¢X , and patients with
                                    sunburn should be advised not to use the product until fully
                                    recovered because of heightened susceptibility to sunlight as a
                                    result of the use of tretinoin.Patients who may be required to
                                    have considerable sun exposure due to occupation and those with
                                    inherent sensitivity to the sun should exercise particular
                                    caution.Â Use of sunscreen products and protective clothing
                                    over treated areas is recommended when exposure cannot be
                                    avoided.Weather extremes, such as <span class="product-label-link" type="condition" conceptid="4221803" conceptname="Flatus">wind</span> or <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">cold</span>,also may be
                                    irritating to patients under treatment with
                                    tretinoin.</p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                                    TRETINâ€¢X preparations for <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> treatment should be kept
                                    away from the eyes,the mouth,angles of the nose, and mucous
                                    membranes.Topical use may induce severe local <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span> and
                                    <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span> at the site of application.If the degree of local
                                    irritation warrants,patients should be directed to use the
                                    medication less frequently,discontinue use temporarily,or
                                    discontinue use altogether.Tretinoin has been reported to cause
                                    severe irritation on eczematous skin and should be used with
                                    utmost caution in patients with this
                                condition.</p>
</div>
<div class="Section" data-sectionCode="34073-7">
<a name="e2899a93-07aa-4841-aba7-5d4997fa3b10"></a><a name="section-6.2"></a><p></p>
<h2>Drug Interactions</h2>
<p class="First">Concomitant topical medication,medicated or abrasive
                                    soaps and cleansers,soaps and cosmetics that have a strong
                                    drying effect,and products with high concentrations of
                                    alcohol,astringents,spices or lime should be used with caution
                                    because of possible interaction with tretinoin.Particular
                                    caution should be exercised in using preparations containing
                                    sulfur,resorcinol,or salicylic acid with TRETINâ€¢X. It also
                                    is advisable to â€œrestâ€? a patientâ€™s skin until
                                    the effects of such preparations subside before use of
                                    Â TRETINâ€¢X is begun.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="d125a911-1886-453b-aa48-0e15a8e42c49"></a><a name="section-6.3"></a><p></p>
<h2>Carcinogenesis, Mutagenesis,
                                ImpairmentÂ toÂ Fertility</h2>
<p class="First">In a 91-week dermal study in which CD-1 mice were
                                    administered 0.017% and 0.035% formulations of
                                    tretinoin,cutaneous squamous cell carcinomas and <span class="product-label-link" type="condition" conceptid="4034142" conceptname="Papilloma">papillomas</span> in
                                    the treatment area were observed in some female mice.A
                                    dose-related incidence of <span class="product-label-link" type="condition" conceptid="4322895" conceptname="Nodule of liver">liver tumors</span> in male mice was observed
                                    at those same doses.The maximum systemic doses associated with
                                    the administered 0.017% and 0.035% formulations are 0.5
                                    and 1.0 mg/kg/day, respectively.These doses are two and four
                                    times the maximum human systemic dose,when adjusted for total
                                    body surface area.The biological significance of these findings
                                    is not clear because they occurred at doses that exceeded the
                                    dermal maximally tolerated dose (MTD) of tretinoin and because
                                    they were within the background natural occurrence rate for
                                    these tumors in this <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strain</span> of mice.There was no evidence of
                                    carcinogenic potential when 0.025 mg/kg/day of tretinoin was
                                    administered topically to mice (0.1 times the maximum human
                                    systemic dose,adjusted for total body surface area). For
                                    purposes of comparisons of the animal exposure to systemic human
                                    exposure,the maximum human systemic dose is defined as 1 gram of
                                    0.1% TRETINâ€¢X Â applied daily to a 50 kg person
                                    (0.02 mg tretinoin/kg body weight).
                                    </p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                                    Studies in hairless albino mice suggest that concurrent exposure
                                    to tretinoin may enhance the tumorigenic potential of
                                    carcinogenic doses of UVB and UVA light form a solar
                                    simulator.This effect has been confirmed in a later study in
                                    pigmented mice,and dark <span class="product-label-link" type="condition" conceptid="4083855" conceptname="Abnormal pigment">pigmentation</span> did not overcome the
                                    enhancement of photocarcinogenesis by 0.05%
                                    tretinoin.Although the significance of these studies to humans
                                    is not clear,patients should minimize exposure to sunlight or
                                    artificial ultraviolet irradiation sources.
                                    </p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                                    The mutagenic potential of tretinoin was evaluated in the Ames
                                    assay and in the in vivo mouse micronucleus assay,both of which
                                    were negative.
                                    </p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                                    In dermal Segment I fertility studies of tretinoin in
                                    rats,slight (not statistically significant) decreases in sperm
                                    count and motility were seen at 0.5 mg/kg/day (4 times the
                                    maximum human systemic dose adjusted for total body surface
                                    area) and slight (not statistically significant) increases in
                                    the number and percent of nonviable embryos in females treated
                                    with 0.25 mg/kg/day (2 times the maximum human systemic dose
                                    adjusted for total body surface area) and above were observed.A
                                    dermal Segment III study with TRETINâ€¢X has not been
                                    performed in any species.In oral Segment I and Segment III
                                    studies in rats with tretinoin,decreased survival of neonates
                                    and <span class="product-label-link" type="condition" conceptid="4245750" conceptname="Growth retardation">growth retardation</span> were observed at doses in excess of 2
                                    mg/kg/day (16 times the human topical dose adjusted for total
                                    body surface area). </p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="e66288ee-2f17-48fc-a953-37aeab4c9cc5"></a><a name="section-6.4"></a><p></p>
<h2>Pregnancy</h2>
<p class="First">Teratogenic effects.Pregnancy Category C.<span class="Underline"><span class="Emphasis">Oral</span></span> tretinoin has been shown to be
                                    teratogenic in rats,mice,hamsters and subhuman primates.It was
                                    teratogenic and fetotoxic in Wistar rats when given orally or
                                    topically in doses greater than 1 mg/kg/day (8 times the maximum
                                    human systemic dose adjusted for total body surface
                                    area).However,variations in teratogenic doses among various
                                    <span class="product-label-link" type="condition" conceptid="4168796" conceptname="Muscle strain">strains</span> of rats have been reported. In the cynomolgus monkey,
                                    which metabolically is closer to humans for tretinoin than the
                                    other species examined, <span class="product-label-link" type="condition" conceptid="4079975" conceptname="Congenital malformation">fetal malformations</span> were reported at
                                    doses of 10 mg/kg/day or greater,but none were observed at 5
                                    mg/kg/day (83 times the maximum human systemic dose adjusted for
                                    total body surface area),although increased skeletal variations
                                    were observed at all doses.A dose-related increase in
                                    embryolethality and abortion was reported. Similar results have
                                    also been reported in pigtail macaques.
                                    </p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                                        <span class="Underline"><span class="Emphasis">Topical</span></span> tretinoin in animal
                                    <span class="product-label-link" type="condition" conceptid="4240324" conceptname="Teratogenesis">teratogenicity</span> tests has generated equivocal results.There is
                                    evidence for <span class="product-label-link" type="condition" conceptid="4240324" conceptname="Teratogenesis">teratogenicity</span> (shortened or kinked tail) of
                                    topical tretinoin in Wistar rats at doses greater than 1
                                    mg/kg/day (8 times the maximum human systemic dose adjusted for
                                    total body surface area).Anomalies (humerus: short 13%, bent
                                    6%, os parietal incompletely ossified 14%) have also
                                    been reported when 10 mg/kg/day was topically applied.
                                    </p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                                    There are other reports in New Zealand White rabbits
                                    administered doses of greater than 0.2 mg/kg/day (3.3 times the
                                    maximum human systemic dose adjusted for total body surface
                                    area) of an increased incidence of domed head and
                                    <span class="product-label-link" type="condition" conceptid="4043738" conceptname="Hydrocephalus">hydrocephaly</span>,typical of retinoid-induced <span class="product-label-link" type="condition" conceptid="4079975" conceptname="Congenital malformation">fetal malformations</span> in
                                    this species.
                                    </p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                                    In contrast,several well-controlled animal studies have shown
                                    that dermally applied tretinoin may be fetotoxic, but not overly
                                    teratogenic in rats and rabbits at doses of 1.0 and 0.5
                                    mg/kg/day,respectively (8 times the maximum human systemic dose
                                    adjusted for total body surface area in both species).
                                    </p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                                    With widespread use of any drug, a small number of birth defect
                                    reports associated temporally with the administration of the
                                    drug would be expected by chance alone.Thirty human cases of
                                    temporally associated congenital malformations have been
                                    reported during two decades of clinical use of
                                    tretinoin.Although no definite pattern of <span class="product-label-link" type="condition" conceptid="4240324" conceptname="Teratogenesis">teratogenicity</span> and no
                                    causal association has been established from these cases,five of
                                    the reports describe the rare birth defect category
                                    <span class="product-label-link" type="condition" conceptid="4149584" conceptname="Holoprosencephaly sequence">holoprosencephaly</span> (defects associated with incomplete midline
                                    development of the forebrain).The significance of these
                                    spontaneous reports in terms of risk to the fetus is not known.
                                </p>
</div>
<div class="Section" data-sectionCode="34078-6">
<a name="a40cb46f-e4ff-467e-9f4f-fd5bd3a03465"></a><a name="section-6.5"></a><p></p>
<h2>Nonteratogenic Effects</h2>
<p class="First">Topical tretinoin has been shown to be fetotoxic in
                                    rabbits when administered 0.5 mg/kg/day (8 times the maximum
                                    human systemic dose adjusted for total body surface area).Oral
                                    tretinoin has been shown to be fetotoxic, resulting in skeletal
                                    variations and increased intrauterine <span class="product-label-link" type="condition" conceptid="4306655" conceptname="Death">death</span> in rats when
                                    administered 2.5 mg/kg/day (20 times the maximum human systemic
                                    dose adjusted for total body surface area).
                                    Â Â Â Â Â Â Â 
                                    </p>
<p>There are no adequate and well-controlled
                                    studies in pregnant women.Tretinoin should be used during
                                    pregnancy only if the potential benefit justifies the potential
                                    risk to the fetus.</p>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="eb9862ff-b06c-4206-ad32-7f4593107ae0"></a><a name="section-6.6"></a><p></p>
<h2>Nursing Mothers</h2>
<p class="First">It is not known whether this drug is excreted in human
                                    milk.Because many drugs are excreted in human milk,caution
                                    should be exercised when TRETINâ€¢X Â is used by a
                                    nursing
                                    woman.</p>
<p>Â </p>
<p>Â </p>
</div>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="aea88613-d052-434e-840e-ffba1e0d2783"></a><a name="section-7"></a><p></p>
<h1>Pediatric Use</h1>
<p class="First">Safety and effectiveness in pediatric patients below the age of
                            12 have not been established.</p>
</div>
<div class="Section" data-sectionCode="34082-8">
<a name="bf95e3ea-1924-445f-9726-dbd6d826fe14"></a><a name="section-8"></a><p></p>
<h1>GeriatricÂ Use</h1>
<p class="First">Safety and effectiveness in a geriatric population have not
                            been established. Clinical studies of tretinoin did not include
                            sufficient numbers of subjects aged 65 and over to determine whether
                            they respond differently from younger patients.</p>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="cc24b3cb-aa44-4de0-be88-234e9ac59755"></a><a name="section-9"></a><p></p>
<h1>Adverse Reactions</h1>
<p class="First">The skin of certain sensitive individuals may become
                            excessively red,edematous,blistered, or crusted.If these effects
                            occur,the medication should either be discontinued until the integrity
                            of the skin is restored,or the medication should be adjusted to a level
                            the patient can tolerate.True contact <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span> to topical tretinoin is
                            rarely encountered. Temporary hyper- or hypopigmentation has been
                            reported with repeated application of a tretinoin preparation.Some
                            individuals have been reported to have heightened susceptibility to
                            sunlight while under treatment with tretinoin.To date,all adverse
                            effects of tretinoin have been reversible upon discontinuance of therapy
                                <span class="Bold"><span class="Emphasis">(see
                                        <a href="#dd2dcc66-8e4c-4802-b3bf-f348853e9746">Dosage and Administration
                                Section</a>).</span></span></p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="b4dd7245-9c81-46af-a547-d0fc622885fe"></a><a name="section-10"></a><p></p>
<h1>Overdosage</h1>
<p class="First">If medication is applied excessively, no more rapid or better
                            results will be obtained and marked <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span>,<span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span>,or <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> may
                            occur.Oral ingestion of the drug may lead to the same side effects as
                            those associated with excessive oral intake of Vitamin
                        A.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="dd2dcc66-8e4c-4802-b3bf-f348853e9746"></a><a name="section-11"></a><p></p>
<h1>Dosage &amp; Administration</h1>
<p class="First">TRETINâ€¢X cream should be applied once a day,before
                            retiring, to the skin where <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> lesions appear,using enough to cover
                            the entire affected area
                            lightly.</p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                            Application may cause a transitory <span class="product-label-link" type="condition" conceptid="4141161" conceptname="Hot">feeling of warmth</span> or slight
                            <span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">stinging</span>.In cases where it has been necessary to temporarily discontinue
                            therapy or to reduce the frequency of application,therapy may be resumed
                            or frequency of application increased when the patients become able to
                            tolerate the
                            treatment.</p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                            Alterations of vehicle, drug concentration,or dose frequency should be
                            closely monitored by careful observation of the clinical therapeutic
                            response and skin
                            tolerance.</p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                            During the early weeks of therapy,an <span class="Italics"><span class="Emphasis">apparent</span></span>
                            exacerbation of inflammatory lesions may occur.This is due to the action
                            of the medication on deep,previously unseen lesions and should not be
                            considered a reason to discontinue
                            therapy.</p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                            Therapeutic results should be noticed after two to three weeks but more
                            than six weeks of therapy may be required before definite beneficial
                            effects are
                            seen.</p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                            Once the <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> lesions have responded satisfactorily,it may be possible
                            to maintain the improvement with less frequent applications,or other
                            dosage
                            forms.</p>
<p>Â Â Â Â Â Â Â Â Â Â Â 
                            Patients treated with TRETINâ€¢X preparations may use cosmetics, but
                            the areas to be treated should be cleansed thoroughly before the
                            medication is applied <span class="Bold"><span class="Emphasis">(see <a href="#e183aaa3-05e3-46d5-87d6-d90fd4088e28">Precautions</a>)</span></span>.</p>
</div>
<div class="Section" data-sectionCode="59845-8">
<a name="da0e2ff7-61c4-4410-b6bf-65beb55152fa"></a><a name="section-12"></a><p></p>
<h1>Patient Instructions</h1>
<p class="First"><span class="Bold"><span class="Emphasis"><span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">Acne</span> Treatment</span></span><br><span class="Bold"><span class="Emphasis">IMPORTANT</span></span><br>
                            Read Directions Carefully Before Using</p>
<p><span class="Bold"><span class="Emphasis">Read Directions Carefully Before Using.</span></span></p>
<p><span class="Bold"><span class="Emphasis">THIS LEAFLET TELLS YOU ABOUT TRETINâ€¢X <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">ACNE</span> TREATMENT AS PRESCRIBED BY YOUR PHYSICIAN. THIS PRODUCT IS TO BE USED ONLY ACCORDING TO YOUR DOCTOR'S INSTRUCTIONS, AND IT SHOULD NOT BE APPLIED TO OTHER AREAS OF THE BODY OR TO OTHER GROWTHS OR LESIONS. THE LONG-TERM SAFETY AND EFFECTIVENESS OF THIS PRODUCT IN OTHER DISORDERS HAVE NOT BEEN EVALUATED. IF YOU HAVE ANY QUESTIONS, BE SURE TO ASK YOUR DOCTOR</span></span>. </p>
<p><span class="Bold"><span class="Emphasis">WARNINGS</span></span></p>
<p>Keep out of reach of children. Keep tube tightly closed. Do not expose to heat or store at temperatures above 120Â°F (49Â°C).</p>
<p><span class="Bold"><span class="Emphasis">PRECAUTIONS</span></span></p>
<p><span class="Bold"><span class="Emphasis">The effects of the sun on your skin.</span></span> As you know, overexposure to natural sunlight or the artificial sunlight of a sunlamp can cause sunburn. Overexposure to the sun over many years may cause <span class="product-label-link" type="condition" conceptid="4227583" conceptname="Premature aging">premature aging</span> of the skin and even skin cancer. The chances of these effects occurring will vary depending on skin type, the climate and the care taken to avoid overexposure to the sun. Therapy with TRETINâ€¢X may make your skin more susceptible to sunburn and other adverse effects of the sun, so unprotected exposure to natural or artificial sunlight should be minimized.</p>
<p><span class="Bold"><span class="Emphasis">Laboratory findings.</span></span> When laboratory mice are exposed to artificial sunlight, they often develop <span class="product-label-link" type="condition" conceptid="135777" conceptname="Neoplasm of uncertain behavior of skin">skin tumors</span>. These sunlight-induced tumors may appear more quickly and in greater number if the mouse is also topically treated with the active ingredient in TRETINâ€¢X, tretinoin. In some studies, under different conditions, however, when mice treated with TRETINâ€¢X were exposed to artificial sunlight, the incidence and rate of development of <span class="product-label-link" type="condition" conceptid="135777" conceptname="Neoplasm of uncertain behavior of skin">skin tumors</span> was reduced. There is no evidence to date that TRETIN-X alone will cause the development of <span class="product-label-link" type="condition" conceptid="135777" conceptname="Neoplasm of uncertain behavior of skin">skin tumors</span> in either laboratory animals or humans. However, investigations in this area are continuing.</p>
<p><span class="Bold"><span class="Emphasis">Use caution in the sun.</span></span> When outside, even on hazy days, areas treated with TRETINâ€¢X should be protected. An effective sunscreen should be used <span class="Underline"><span class="Emphasis">any time you are outside</span></span> (consult your physician for a recommendation of an SPF level which will provide you with the necessary high level of protection). For extended sun exposure, protective clothing, like a hat, should be worn. Do not use artificial sunlamps while you are using TRETINâ€¢X. If you do become sunburned, stop your therapy with TRETIN-X until your skin has recovered.</p>
<p><span class="Bold"><span class="Emphasis">Avoid excessive exposure to <span class="product-label-link" type="condition" conceptid="4221803" conceptname="Flatus">wind</span> or <span class="product-label-link" type="condition" conceptid="260427" conceptname="Common cold">cold</span>.</span></span> Extremes of climate tend to dry or burn normal skin. Skin treated with TRETINâ€¢X may be more vulnerable to these extremes. Your physician can recommend ways to manage your <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> treatment under such conditions.</p>
<p><span class="Bold"><span class="Emphasis">Possible problems.</span></span> The skin of certain sensitive individuals may become excessively red, swollen, blistered or crusted. If you are experiencing severe or persistent irritation, discontinue the use of TRETIN-X and consult your physician.</p>
<p>There have been reports that, in some patients, areas treated with TRETINâ€¢X developed a temporary increase or decrease in the amount of skin pigment (color) present. The pigment in these areas returned to normal either when the skin was allowed to adjust to TRETINâ€¢X or therapy was discontinued.</p>
<p><span class="Bold"><span class="Emphasis">Use other medication only on your doctor's advice.</span></span> Only your physician knows which other medications may be helpful during treatment and will recommend them to you if necessary. Follow the physician's instructions carefully. In addition, you should avoid preparations that may dry or irritate your skin. These preparations may include certain astringents, toiletries containing alcohol, spices or lime, or certain medicated soaps, shampoos and hair permanent solutions. Do not allow anyone else to use this medication.</p>
<p>Do not use other medications with TRETINâ€¢X which are not recommended by your doctor. The medications you have used in the past might cause unnecessary <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">redness</span> or <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span>.</p>
<p><span class="Bold"><span class="Emphasis">If you are pregnant, think you are pregnant or are nursing an infant:</span></span> No studies have been conducted in humans to establish the safety of TRETINâ€¢X in pregnant women. If you are pregnant, think you are pregnant, or are nursing a baby, consult your physician before using this medication.</p>
<p><span class="Bold"><span class="Emphasis">AND WHILE YOU'RE ON TRETINâ€¢X THERAPY</span></span></p>
<p><span class="Italics"><span class="Emphasis">Use a mild, non-medicated soap. Avoid frequent washings and harsh scrubbing.</span></span> <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">Acne</span> isn't caused by dirt, so no matter how hard you scrub, you can't wash it away. Washing too frequently or scrubbing too roughly may at times actually make your <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> worse. Wash your skin gently with a mild, bland soap. Two or three times a day should be sufficient. Pat <span class="product-label-link" type="condition" conceptid="4039266" conceptname="Dry skin">skin dry</span> with a towel. Let the face dry 20-30 minutes before applying TRETINâ€¢X. Remember, excessive irritation such as rubbing, too much washing, use of other medications not suggested by your physician, etc., may worsen your <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span>.</p>
<p><span class="Bold"><span class="Emphasis">HOW TO USE TRETINâ€¢X</span></span></p>
<p>To get the best results with TRETINâ€¢X therapy, it is necessary to use it properly. Forget about the instructions given for other products and the advice of friends. Just stick to the special plan your doctor has laid out for you and be patient. Remember, when TRETINâ€¢X is <span class="Italics"><span class="Emphasis">used properly</span></span>, many users see improvement by 12 weeks. AGAIN, FOLLOW INSTRUCTIONS - BE PATIENT - DON'T START AND STOP THERAPY ON YOUR OWN - IF YOU HAVE QUESTIONS, ASK YOUR DOCTOR.</p>
<p>To help you use the medication correctly, keep these simple instructions in mind.</p>
<ul>
<li>Apply TRETINâ€¢X once daily before bedtime, or as directed by your physician. Your physician may advise, especially if your skin is sensitive, that you start your therapy by applying TRETINâ€¢X every other night. First, wash with a mild soap and dry your skin gently. WAIT 20 to 30 MINUTES BEFORE APPLYING MEDICATION; it is important for skin to be completely dry in order to minimize possible irritation.</li>
<li>It is better not to use more than the amount suggested by your physician or to apply more frequently than instructed. Too much may irritate the skin, waste medication and won't give faster or better results.</li>
<li>Keep the medication away from the corners of the nose, mouth, eyes, and open <span class="product-label-link" type="condition" conceptid="4029919" conceptname="Wound">wounds</span>. <span class="Italics"><span class="Emphasis">Spread away from these areas when applying.</span></span>
</li>
<li>TRETINâ€¢X Cream: Squeeze about a half inch or less of medication onto the fingertip. While that should be enough for your whole face, after you have some experience with the medication you may find you need slightly more or less to do the job. The medication should become invisible almost immediately. If it is still visible, you are using too much. Cover the affected area lightly with TRETINâ€¢X cream by first dabbing it on your forehead, chin and both cheeks, then spreading it over the entire affected area. Smooth gently into the skin.</li>
<li>It is recommended that you apply a moisturizer or a moisturizer with sunscreen that will not aggravate your <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> (noncomedogenic) every morning after you wash.</li>
</ul>
<p><span class="Bold"><span class="Emphasis">WHAT TO EXPECT WITH YOUR NEW TREATMENT</span></span></p>
<p>TRETINâ€¢X works deep inside your skin and this takes time. You cannot make TRETINâ€¢X work any faster by applying more than one dose each day, but an excess amount of TRETINâ€¢X may irritate your skin. Be patient.</p>
<p>There may be some <span class="product-label-link" type="condition" conceptid="4090431" conceptname="Discomfort">discomfort</span> or <span class="product-label-link" type="condition" conceptid="4032013" conceptname="Desquamation">peeling</span> during the early days of treatment. Some patients also notice that their skin begins to take on a blush.</p>
<p>These reactions do not happen to everyone. If they do, it is just your skin adjusting to TRETINâ€¢X and this usually subsides within two to four weeks. These reactions can usually be minimized by following instructions carefully. <span class="Italics"><span class="Emphasis">Should the effects become excessively troublesome, consult your doctor.</span></span></p>
<p>BY THREE TO SIX WEEKS, some patients notice an appearance of new blemishes (<span class="product-label-link" type="condition" conceptid="4105835" conceptname="Papule">papules</span> and <span class="product-label-link" type="condition" conceptid="4158333" conceptname="Pustule">pustules</span>). At this stage it is <span class="Italics"><span class="Emphasis">important to continue</span></span> using TRETINâ€¢X.</p>
<p>If TRETINâ€¢X is going to have a beneficial effect for you, you should notice a continued improvement in your appearance after 6 to 12 weeks of therapy. Don't be discouraged if you see no immediate improvement. Don't stop treatment at the first signs of improvement.</p>
<p>Once your <span class="product-label-link" type="condition" conceptid="141095" conceptname="Acne">acne</span> is under control you should continue regular application of TRETINâ€¢X until your physician instructs otherwise.</p>
<p><span class="Bold"><span class="Emphasis">IF YOU HAVE QUESTIONS</span></span></p>
<p>All questions of a medical nature should be taken up with your doctor. For more information about TRETINâ€¢X, call our toll-free number: 1-800-978-5060. Call between 9:00 a.m. and 3:00 p.m. Eastern Time, Monday through Friday.</p>
<p>Manufactured for Onset Dermatologics, LLC<br>
                            Cumberland, RI  02864<br>
                            by DPT Laboratories, San Antonio, TX 78215</p>
<p>P/N2634 R2</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="f38c96fa-e70d-4272-ad83-0e2e7fae0cc1"></a><a name="section-13"></a><p></p>
<h1>How Supplied</h1>
<p class="First"><span class="Bold"><span class="Emphasis">TRETINâ€¢X</span></span>Â <span class="Bold"><span class="Emphasis">Â Cream,
                                USP</span></span></p>
<table width=" 253px"><tbody class="Headless">
<tr class="First">
<td class="Botrule Lrule Rrule Toprule">NDC
                                        CODEÂ Â </td>
<td class="Botrule Lrule Rrule Toprule">Strength</td>
<td class="Botrule Lrule Rrule Toprule">Qty.Â </td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule">16781-379-35</td>
<td class="Botrule Lrule Rrule Toprule">Â 0.1%</td>
<td class="Botrule Lrule Rrule Toprule">35g</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule">16781-446-35</td>
<td class="Botrule Lrule Rrule Toprule">Â 0.075%</td>
<td class="Botrule Lrule Rrule Toprule">35g</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule">16781-376-35</td>
<td class="Botrule Lrule Rrule Toprule">Â 0.0375%</td>
<td class="Botrule Lrule Rrule Toprule">35g</td>
</tr>
<tr>
<td class="Botrule Lrule Rrule Toprule">16781-378-35</td>
<td class="Botrule Lrule Rrule Toprule">Â 0.05%</td>
<td class="Botrule Lrule Rrule Toprule">35g</td>
</tr>
<tr class="Last">
<td class="Botrule Lrule Rrule Toprule">16781-375-35</td>
<td class="Botrule Lrule Rrule Toprule">Â 0.025%</td>
<td class="Botrule Lrule Rrule Toprule">35g</td>
</tr>
</tbody></table>
<p><span class="Bold"><span class="Emphasis">Storage Conditions:
                            </span></span></p>
<p>TRETINâ€¢XÂ  Cream,
                            USP: Â store below 27Â°C
                            (80Â°F)</p>
<p>TRETINâ€¢X is a registered
                            trademark of Onset
                                Dermatologics,LL</p>
<p><img alt="Onset DERMATOLOGICS" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1cecc7e2-00bd-4c63-af1d-723aaf892f60&amp;name=tretinx-figure-2-Onset_DERMATOLOGICS.jpg">Â Â Â Â Manufactured for
                            Onset
                            Dermatologics,LLC</p>
<p>Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Cumberland,
                            RI
                            02864</p>
<p>Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â by
                            DPT Laboratories, San Antonio,TX
                            78215</p>
<p>Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â P/N2634
                            R2</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="d50e2b59-2c51-49d8-aae2-9fd8c7ae2823"></a><a name="section-14"></a><p></p>
<h1>PACKAGE LABEL.PRINCIPAL DISPLAY PANEL</h1>
<p class="First">Package Label-Principal Display Panel- 35g Carton Tretinâ€¢X CreamÂ  tretinoin
                            0.1%</p>
<p><img alt="tretinx-figure-3-carton_TretinX_0.1" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1cecc7e2-00bd-4c63-af1d-723aaf892f60&amp;name=tretinx-figure-3-tretinx-figure-3-carton_TretinX_0.1.jpg"></p>
<p>Package
                                    Label-Principal Display Panel- 35g Carton Tretinâ€¢X CreamÂ  tretinoin
                            0.075%</p>
<p><img alt="tretinx-figure-4-carton_TretinX_0.075" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1cecc7e2-00bd-4c63-af1d-723aaf892f60&amp;name=tretinx-figure-4-tretinx-figure-4-carton_TretinX_0.075.jpg"></p>
<p>Package
                                    Label-Principal Display Panel- 35g Carton Tretinâ€¢X CreamÂ  tretinoin
                            0.05%</p>
<p>Â </p>
<p><img alt="tretinx-figure-5-carton_TretinX_0.05" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1cecc7e2-00bd-4c63-af1d-723aaf892f60&amp;name=tretinx-figure-5-tretinx-figure-5-carton_TretinX_0.05.jpg"></p>
<p>Package
                                    Label-Principal Display Panel- 35g Carton Tretinâ€¢X CreamÂ  tretinoin
                            0.0375%</p>
<p><img alt="tretinx-figure-6-carton_TretinX_0.0375" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1cecc7e2-00bd-4c63-af1d-723aaf892f60&amp;name=tretinx-figure-6-tretinx-figure-6-carton_TretinX_0.0375.jpg"></p>
<p>Â </p>
<p>Package
                                Label-Principal Display Panel- 35g Carton Tretinâ€¢X CreamÂ  tretinoin
                            0.025%</p>
<p><img alt="tretinx-figure-7-carton_TretinX_0.025" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=1cecc7e2-00bd-4c63-af1d-723aaf892f60&amp;name=tretinx-figure-7-tretinx-figure-7-carton_TretinX_0.025.jpg"></p>
<p>Â </p>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>TRETIN.XÂ 		
					</strong><br><span class="contentTableReg">tretinoin cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:16781-375</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TRETINOIN</strong> (TRETINOIN) </td>
<td class="formItem">TRETINOIN</td>
<td class="formItem">0.25Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STEARIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ISOPROPYL MYRISTATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYOXYL 40 STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>XANTHAN GUM</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SORBIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>BUTYLATED HYDROXYTOLUENE</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:16781-375-35</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">35 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA075264</td>
<td class="formItem">04/02/2013</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>TRETIN.XÂ 		
					</strong><br><span class="contentTableReg">tretinoin cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:16781-376</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TRETINOIN</strong> (TRETINOIN) </td>
<td class="formItem">TRETINOIN</td>
<td class="formItem">0.375Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STEARIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ISOPROPYL MYRISTATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYOXYL 40 STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>XANTHAN GUM</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SORBIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>BUTYLATED HYDROXYTOLUENE</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:16781-376-35</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">35 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA090098</td>
<td class="formItem">04/02/2013</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>TRETIN.XÂ 		
					</strong><br><span class="contentTableReg">tretinoin cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:16781-378</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TRETINOIN</strong> (Tretinoin) </td>
<td class="formItem">TRETINOIN</td>
<td class="formItem">0.5Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STEARIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ISOPROPYL MYRISTATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYOXYL 40 STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>XANTHAN GUM</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SORBIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>BUTYLATED HYDROXYTOLUENE</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:16781-378-35</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">35 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA075265</td>
<td class="formItem">04/02/2013</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>TRETIN.XÂ 		
					</strong><br><span class="contentTableReg">tretinoin cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:16781-379</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TRETINOIN</strong> (TRETINOIN) </td>
<td class="formItem">TRETINOIN</td>
<td class="formItem">1Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STEARIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ISOPROPYL MYRISTATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYOXYL 40 STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>XANTHAN GUM</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SORBIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>BUTYLATED HYDROXYTOLUENE</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:16781-379-35</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">35 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA075213</td>
<td class="formItem">04/02/2013</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>TRETIN.XÂ 		
					</strong><br><span class="contentTableReg">tretinoin cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:16781-446</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">Â Â Â Â 
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>TRETINOIN</strong> (Tretinoin) </td>
<td class="formItem">TRETINOIN</td>
<td class="formItem">0.75Â mg Â inÂ 1Â g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>STEARIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>ISOPROPYL MYRISTATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>POLYOXYL 40 STEARATE</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>STEARYL ALCOHOL</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>XANTHAN GUM</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SORBIC ACID</strong></td>
<td class="formItem">Â </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>BUTYLATED HYDROXYTOLUENE</strong></td>
<td class="formItem">Â </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:16781-446-35</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">35 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">ANDA</td>
<td class="formItem">ANDA202209</td>
<td class="formItem">04/02/2013</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler -Â </span>Onset Dermatologics LLC
							(793223707)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Registrant -Â </span>Precision Dermatology, Inc. (056267369)</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">DPT Laboratories, Inc.</td>
<td class="formItem"></td>
<td class="formItem">832224526</td>
<td class="formItem">manufacture(16781-379)</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">BASF PharmaChemikalien GmbH &amp; Co. KG</td>
<td class="formItem"></td>
<td class="formItem">328633636</td>
<td class="formItem">api manufacture(16781-379)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 5/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>8c1d234a-e5ed-4ec7-81f0-e74713518f07</div>
<div>Set id: 1cecc7e2-00bd-4c63-af1d-723aaf892f60</div>
<div>Version: 4</div>
<div>Effective Time: 20130517</div>
</div>
</div>Â <div class="DistributorName">Onset Dermatologics LLC</div></p>
</body></html>
